Holen Sie sich die Stockscreener-App
619.01
0.05%
0.29
Handel nachbörslich:
619.01
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TMO?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$618.72
Offen:
$609.5
24-Stunden-Volumen:
3.11M
Relative Volume:
1.69
Marktkapitalisierung:
$232.57B
Einnahmen:
$43.74B
Nettoeinkommen (Verlust:
$6.58B
KGV:
35.77
EPS:
17.3072
Netto-Cashflow:
$6.11B
1W Leistung:
+1.97%
1M Leistung:
+9.01%
6M Leistung:
+49.25%
1J Leistung:
+10.61%
1-Tages-Spanne:
$606.00
$620.85
1-Wochen-Bereich:
$606.00
$629.87
52-Wochen-Spanne:
$385.46
$629.87
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Firmenname
Thermo Fisher Scientific Inc
Sektor
Branche
Telefon
(781) 622-1000
Adresse
168 THIRD AVENUE, WALTHAM, MA
Vergleichen Sie TMO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
619.01 | 232.46B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
234.33 | 166.69B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
686.02 | 57.12B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
233.69 | 40.48B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
135.83 | 39.59B | 6.95B | 1.30B | 1.15B | 4.5696 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Goldman | Buy |
| 2025-12-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-12-01 | Hochstufung | HSBC Securities | Hold → Buy |
| 2025-09-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Eingeleitet | William Blair | Outperform |
| 2025-07-24 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-03-18 | Fortgesetzt | Citigroup | Neutral |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Eingeleitet | HSBC Securities | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-10-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-06 | Fortgesetzt | Citigroup | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-07-19 | Bestätigt | Robert W. Baird | Outperform |
| 2023-07-13 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Bestätigt | Barclays | Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Fortgesetzt | Barclays | Overweight |
| 2021-10-20 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Bestätigt | Needham | Buy |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2020-01-22 | Eingeleitet | Credit Suisse | Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-25 | Bestätigt | Needham | Buy |
| 2019-07-16 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-05-23 | Bestätigt | Needham | Strong Buy |
| 2019-04-22 | Bestätigt | Needham | Strong Buy |
| 2019-04-16 | Bestätigt | BofA/Merrill | Buy |
Alle ansehen
Thermo Fisher Scientific Inc Aktie (TMO) Neueste Nachrichten
Thermo Fisher stock price holds near $619 after-hours as tariff fears slam Wall Street - TechStock²
Thermo Fisher Scientific and NVIDIA Partner to Advance Laboratory AI Automation - Lab Manager
Peering Into Thermo Fisher Scientific Inc's Recent Short Interest - Benzinga
Thermo Fisher stock slips as Australia opens Clario deal review — what investors watch next - TechStock²
Single-Use Bioprocessing Market Projected to Reach US$ 122.92 Billion by 2035, Supported by Expansion of Biomanufacturing Capacity Says Astute Analytica - GlobeNewswire Inc.
Thermo Fisher's proposal to acquire Clario Holdings to be reviewed in Australia - MLex
Thermo Fisher Scientific Inc. (TMO): A Bull Case Theory - Finviz
Thermo Fisher Scientific Inc.: BCC Research Releases Comprehensive 360° Company Analysis - GlobeNewswire
The Zacks Analyst Blog Highlights Visa, Advanced Micro Devices and Thermo Fisher Scientific - Yahoo Finance
Sepsis Treatment Market Is Going to Boom | Thermo Fisher Scientific • Merck & Co. • Pfizer Inc - openPR.com
Thermo Fisher Scientific Inc. (TMO) and NVIDIA partner to bring advanced AI to lab workflows - MSN
Thermo Fisher Scientific stock drops before long weekend as TMO traders brace for Jan. 29 earnings - TechStock²
Thermo Fisher Scientific Rated Second Best Recession Investment, Price Target Raised to $700 - Intellectia AI
Thermo Fisher Scientific Inc. (TMO) and NVIDIA Partner to Bring Advanced AI to Lab Workflows - Insider Monkey
Thermo Fisher stock pulls back from near-$630: what to know before earnings - TechStock²
Is Thermo Fisher Scientific (TMO) Fairly Priced After Recent Life Sciences Demand Headlines - Yahoo Finance UK
Thermo Fisher Scientific (TMO) Valuation After Leadership Shakeup And New AI Lab Partnerships - simplywall.st
Thermo Fisher Scientific stock slips into long weekend as TMO traders eye Jan. 29 earnings - TechStock²
Top Analyst Reports for Visa, AMD & Thermo Fisher - The Globe and Mail
Investing in Thermo Fisher Scientific (NYSE:TMO) Five Years Ago Would Have Delivered You a 24% Gain - 富途牛牛
A Weaverville facility produces 'humanity saving' equipment. Why is it closing? - citizen-times.com
Thermo Fisher stock price holds near $625 after-hours as earnings date nears and AI push widens - TechStock²
NVIDIA adds Thermo Fisher to growing roster of healthcare AI partnerships at JPM - R&D World
Nvidia Expands AI Healthcare Push With Lilly, Thermo Fisher - TechRepublic
Thermo Fisher Scientific (NYSE:TMO) Reaches New 52-Week HighTime to Buy? - MarketBeat
Thermo Fisher Scientific stock hits 52-week high at $628.33 - Investing.com
Thermo Fisher Scientific stock hits 52-week high at $628.33 By Investing.com - Investing.com Nigeria
Thermo Fisher (TMO) stock rises again as CEO points to U.S. reshoring contracts - TechStock²
Precision Carbon Capture Monitoring for Net Zero Goals - AZoM
Thermo Fisher to shut Asheville plant and lay off its 421 workers. Here’s why. - newsobserver.com
Neonatal Toxicology Market Is Going to Boom |• Thermo Fisher Scientific • PerkinElmer - openPR.com
OVERSEA CHINESE BANKING Corp Ltd Lowers Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Stephens Inc. AR Has $10.62 Million Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Nordea Investment Management AB Has $82.14 Million Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Stock Position Raised by MGO One Seven LLC - MarketBeat
Thermo Fisher partners with NVIDIA leveraging AI to advance scientific instrumentation - BioSpectrum Asia
Conning Inc. Has $5.31 Million Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific stock jumps on reshoring-contract talk, Nvidia tie-up as earnings loom - TechStock²
Thermo Fisher closes manufacturing site, lays off hundreds - The Business Journals
Thermo Fisher Scientific stock rises on reshoring contract talk, Nvidia lab deal and exec shuffle - TechStock²
Thermo Fisher Scientific launches new Niton XL5e Analyzer - International Mining
Manning & Napier Advisors LLC Trims Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Robeco Schweiz AG Reduces Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Should You Continue to Hold Thermo Fisher Stock in Your Portfolio Now? - TradingView — Track All Markets
Exencial Wealth Advisors LLC Has $18.27 Million Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Company Profile – Thermo Fisher Scientific - pharmaphorum
Thermo Fisher Sci.: The Quiet Giant Wall Street Loves (But TikTok Still Sleeps On) - AD HOC NEWS
Thermo Fisher Scientific announces strategic collaboration With NVIDIA - Indian Pharma Post
Will Thermo Fisher’s AI Push and Leadership Shuffle Redefine TMO’s Innovation and Execution Narrative? - simplywall.st
Niton adds to handheld analyzer line - Construction & Demolition Recycling
Thermo Fisher stock falls as CEO flags new U.S. reshoring contracts, Nvidia tie-up in focus - TechStock²
Finanzdaten der Thermo Fisher Scientific Inc-Aktie (TMO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.70%
1.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):